Kyra J. Cowan

机构：Merck KGaA, Darmstadt (Germany), PharmacoGenetics (China) · ORCID：0000-0002-4811-7748

发表论文 83 篇 · 总被引 2208 次 · h-index 22

代表论文

Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum (2024 · Bioanalysis · 被引 23)
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform (2025 · Frontiers in Immunology · 被引 20)
Leveraging Cross-Linking Mass Spectrometry for Modeling Antibody–Antigen Complexes (2024 · Journal of Proteome Research · 被引 16)
Assessing MAPPs assay as a tool to predict the immunogenicity potential of protein therapeutics (2023 · Life Science Alliance · 被引 15)
A European Bioanalysis Forum recommendation for requiring a context-of-use statement for successful development and validation of biomarker assays (2024 · Bioanalysis · 被引 12)
Preclinical risk assessment strategy to mitigate the T-cell dependent immunogenicity of protein biotherapeutics: State of the art, challenges and future perspectives (2023 · Journal of Pharmaceutical and Biomedical Analysis · 被引 12)